In order to combat the immunostimulatory effects of the elevated extracellular ATP in the tumor microenvironment, tumor cells, and tumor-associated immune cells, can overexpress CD39 and/or CD73 to rapidly convert extracellular ATP into immunosuppressive adenosine (24). This evidence concerns the gene ENTPD1 and neoplasm.